Type of Cancer
Skin and Soft Tissue
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.